Departement of Nutrition, Faculty of Medicine, Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.
BMC Res Notes. 2022 Oct 12;15(1):323. doi: 10.1186/s13104-022-06209-7.
This study aimed to determine the effect of intermittent fasting 5:2 on body composition in employees with obesity in Jakarta.
Fifty participants were included; 25 were allocated to the fasting group and 25 to the control group. There was no significant change in fat mass, fat-free mass, skeletal muscle, and BMI (p > 0.05). Significant in-group changes were observed in body weight (p = 0.023) and BMI (p = 0.018) in the fasting group. Dietary intake was similar before and during the intervention. The reduction in macronutrient intake resulted in a statistically significant difference in carbohydrate, protein, and fat intake in the two groups (p < 0.05). Intermittent fasting 5:2 results in weight loss but does not affect fat mass and fat-free mass reductions. None of the between-group differences were clinically relevant.
ClinicalTrials.gov with ID: NCT04319133 registered on 24 March 2020.
本研究旨在确定间歇性禁食 5:2 对雅加达肥胖员工身体成分的影响。
共纳入 50 名参与者,其中 25 名被分配到禁食组,25 名被分配到对照组。脂肪量、去脂体重、骨骼肌和 BMI 均无显著变化(p>0.05)。禁食组的体重(p=0.023)和 BMI(p=0.018)有显著的组内变化。干预前后的膳食摄入量相似。宏量营养素摄入量的减少导致两组间碳水化合物、蛋白质和脂肪摄入量有统计学显著差异(p<0.05)。间歇性禁食 5:2 可导致体重减轻,但对脂肪量和去脂体重的减少没有影响。组间差异均无临床意义。
ClinicalTrials.gov 注册号:NCT04319133,于 2020 年 3 月 24 日注册。